Investor Presentaiton
SAGA¹: South Africa, Sub-Saharan Africa and Cipla Global Access
SA Private Market
20% YoY
ZAR Terms
South Africa
Private
South Africa
Tender
Others (SSA &
CGA)
Q3 Y-o-Y
$ Mn
Q3 Q-o-Q
$ Mn
30
30
33
33
33
28
29
21
29
31
16%
47
55
56
55
Q3 FY19
Q3 FY20
Q2 FY20
Q3 FY20
Cipla
Key Business Highlights
South Africa private market continued the momentum growing over 2 times the market at 6.5% as per IQVIA MAT Dec' 19
Cipla continues to rank as the 3rd largest pharmaceutical corporation within the South African private market, in both volume
and value
Sub-Saharan Africa business grew by 12% on a year on year basis and the CGA business also delivered a growth of 7% over last
year
Investor Presentation: Q3FY20
1. Financial numbers are rounded off
8View entire presentation